Press Release: Synpromics : uniQure incorporates novel synthetic promoter developed by Synpromics in new preclinical target

Edinburgh, UK, 5th December 2018 / Sciad Newswire / Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, developed by Synpromics, in a new preclinical research target.